Quantcast

J&J, Bayer cleared of responsibility in first Xarelto trial

Johnson & Johnson and Bayer AG aren’t responsible for a Xarelto user’s internal bleeding, a jury found in the first trial over the blood-thinning drug. J&J and Bayer didn’t defectively design Xarelto and didn’t mislead a Louisiana man and his doctors about the blood-thinning drug’s health risks, the federal jury in New Orleans found Wednesday. The ruling ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*